Laboratory of Chemical Pharmacology, National Heart, Lung, and Blood Institute, NIH: a short history.
The Laboratory of Chemical Pharmacology (LCP) began in 1950 as the Section of Pharmacology within the National Heart Institute, the National Institutes of Health. Its first chief was Bernard B. Brodie, considered by many to be one of the fathers of modern pharmacology. Since its inception, LCP has made many significant contributions to the fields of pharmacology and toxicology. LCP was among the first to study (a) the effects of drugs on the turnover of serotonin and norepinephrine in brain and other tissues, (b) the absorption of drugs from the gastrointestinal tract and their passage across the blood-brain barrier, (c) the oxidation and reduction of drugs and other foreign compounds by liver microsomal enzymes (later known as the cytochrome P450 enzymes) and inhibitors and inducers of these enzymes, (d) the formation of toxic chemically reactive metabolites of drugs and other foreign compounds, and (e) mechanisms of immunological responses. Approximately 300 scientists worked in LCP during its existence, and they and their collaborators published more than 1,300 papers. This is a short history of the people who worked in it and of their contributions to biomedical sciences.
Gillette
J R
JR
gillettejrrj@erols.com
D000818:Animals; D003903:Deuterium; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D007668:Kidney / Q000187:drug effects; D009316:National Institutes of Health (U.S.); D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010600:Pharmacology; D014481:United States
D004791:Enzyme Inhibitors; D004364:Pharmaceutical Preparations; D003903:Deuterium